Showing 1 - 2 results of 2 for search 'P. Ypma', query time: 0.02s Refine Results
  1. 1
    P18 SKIN EXPRESSION OF P16INK4A, A BIOMARKER FOR CELLULAR SENESCENCE, DOES NOT PREDICT FRAILTY OR TREATMENT OUTCOME IN NEWLY DIAGNOSED MULTIPLE MYELOMA

    P18 SKIN EXPRESSION OF P16INK4A, A BIOMARKER FOR CELLULAR SENESCENCE, DOES NOT PREDICT FRAILTY OR TREATMENT OUTCOME IN NEWLY DIAGNOSED MULTIPLE MYELOMA by F. Smits, K. Groen, C. Stege, M. Seefat, I. Nijhof, N. van de Donk, P. Ypma, S. Zweegman

    Published 2023-05-01
    Get full text
    Article
  2. 2
    P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY

    P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE P... by K. Groen, C. Stege, K. Nasserinejad, K. de Heer, R. van Kampen, R. Leys, N. Thielen, M. Westerman, K. Wu, I. Ludwig, D. Issa, G. Velders, M. Vekemans, N. van de Donk, G. Timmers, F. de Boer, L. Tick, E. van der Spek, E. de Waal, M. Sohne, P. Sonneveld, I. Nijhof, S. Klein, M. Levin, P. Ypma, S. Zweegman

    Published 2023-05-01
    Get full text
    Article

Search Tools: